Risk factors | Adjusted Odds Ratio with 95% Confidence Interval | |||
---|---|---|---|---|
14-day Mortality | p-value | 30-day Mortality | p-value | |
Age ≥ 65 years | 3.19 (0.89–11.50) | 0.311 | 3.36 (1.24–9.13) | 0.024* |
Pitt score ≥ 3 | 2.11 (1.52–2.93) | < 0.001* | 2.15 (1.54–3.01) | < 0.001* |
Charlson score > 4 | 1.06 (0.87–1.30) | 0.298 | 1.03 (0.87–1.22) | 0.752 |
Chronic kidney disease | 0.83 (0.25–2.74) | 0.371 | 2.45 (0.91–6.59) | 0.150 |
Diabetes mellitus | 1.89 (0.62–5.79) | 0.282 | 1.91 (0.74–4.92) | 0.226 |
Indwelling urinary catheters | 2.11 (0.37–12.05) | < 0.001* | 5.43 (1.39–21.23) | < 0.001* |
No infectious disease team consult | 6.38 (1.96–20.72) | < 0.001* | 2.90 (1.04–8.11) | 0.032* |
Previous exposure to antibiotics | 2.87 (0.64–12.79) | 0.351 | 2.04 (0.67–6.27) | 0.168 |
Non-effective empirical therapy | 1.46 (0.35–5.62) | 0.824 | 1.90 (0.52–6.89) | 0.828 |
Hospital-acquired MRSA | 7.05 (1.61–30.85) | 0.021* | 6.12 (1.81–20.72) | 0.017* |
Healthcare-associated MRSA | 3.03 (0.95–9.64) | 0.463 | 3.19 (1.30–7.81) | 0.043* |
Hypoalbuminemia (< 29 g/L) | 1.66 (0.51–5.42) | 0.386 | 3.31 (1.25–8.79) | 0.017* |
Polymicrobial bacteremia | 3.35 (0.43–1.07) | 0.032* | 2.50 (0.95–6.58) | 0.282 |
Inappropriate targeted treatment | 3.38 (0.54–21.19) | 0.694 | 8.08 (1.15–56.86) | 0.024* |
Inappropriate treatment duration | 1.49 (0.48–4.65) | 0.160 | 1.62 (0.61–4.32) | 0.410 |